前收市價 | 13.10 |
開市 | 13.50 |
買盤 | 13.92 x 800 |
賣出價 | 13.98 x 800 |
今日波幅 | 13.45 - 13.97 |
52 週波幅 | 10.92 - 59.99 |
成交量 | |
平均成交量 | 1,074,439 |
市值 | 838.937M |
Beta 值 (5 年,每月) | 0.85 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -8.39 |
業績公佈日 | 2024年4月25日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 21.88 |
Sage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript April 25, 2024 Sage Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.8 EPS, expectations were $-1.63. Sage Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, […]
Sage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales beat the mark. The newly-launched depression drug Zurzuvae drives the company's top line.
Sage Therapeutics (SAGE) delivered earnings and revenue surprises of -10.43% and 28.28%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?